← All stocks

Septerna, Inc.

SEPN Scheduled selling only

CIK 0001984086 #2087 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$126.08K

$0.00 on a plan · $126.08K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$126.08K

$0.00 against sales at will

By person

10 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Long Daniel D.

SVP, Drug Discovery

—

$126.08K (1) scheduled

−$126.08K

96,412

0.2066%

$3.65M

−3.5%

Third Rock Ventures V, L.P. entity

10% owner

—

9,220,847

19.75%

$348.80M

+1,113%

Third Rock Ventures VI, L.P. entity

10% owner

—

4,211,659

9.02%

$159.31M

+33.6%

Finer Jeffrey

Chief Executive Officer

—

826,907

1.77%

$31.28M

+9.5%

RA CAPITAL MANAGEMENT, L.P. entity

Director

—

725,443

1.55%

$27.44M

—

Bhatt Elizabeth

President and COO

—

174,209

0.3732%

$6.59M

0.0%

Ezekowitz Alan

Director

—

117,420

0.2516%

$4.44M

+574.1%

Labrucherie Gil M

Chief Financial Officer

—

40,000

0.0857%

$1.51M

—

Klein Uwe

SVP, Biological Sciences

—

23,008

0.0493%

$870.33K

—

Shaikhly Samira

Chief People Officer

—

793

0.0017%

$30.00K

0.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Long Daniel D.

1 Sep 2026

SVP, Drug Discovery

Sold after exercise

3,333

$37.83

$126.08K

Show all 1 transactions →

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 3,333

History held since 28 Oct 2024